ABT logo

Abbott Laboratories (ABT)

Profile

Full Name

Abbott Laboratories

Ticker Symbol

ABT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.abbott.com

Employees

114000

Key Details

Price

$132.82(+1.48%)

Market cap

$230.35B(Mega cap)

Last Dividend

$0.59

TTM Dividend yield

1.72%

Annual revenue

$41.95B(+4.59% YoY)

Annual EPS

$7.64(+134.36% YoY)

PE ratio

-

Next earnings date

Jul 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$132.82
ABT price is $132.82

30-Day Relative Volume

1.27
ABT 30-day relative volume is 1.27

Price Performance

Price Today change

+1.48%
ABT price is up +1.48% today

Price YTD change

+17.43%
ABT price is up +17.43% since January 1st

Price 1-year change

+25.4%
ABT price is up +25.4% year-on-year

Price 3-year change

+17.72%
ABT price is up +17.72% over the past 3 years

Price Range

Price All-time high

$142.60
ABT price is currently -6.86% below its historical high of $142.60

Price 3-year low

$89.67
ABT price is currently +48.12% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$230.35B
ABT market capitalization is $230.35 billion

Market cap 3-year change

+16.6%
ABT market capitalization is up +16.6% over the past 3 years

Market cap All-time high

$250.14B
ABT market capitalization is currently -7.91% below its historical high of $250.14 billion

Market cap sector rank

99.59%
ABT market capitalization is higher than 99.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.31%
ABT shares outstanding is down -0.31% year-on-year

Shares Outstanding 3-Year Change

-0.95%
ABT shares outstanding is down -0.95% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.21
ABT beta is 0.21

200-day SMA

$119.42
ABT price is currently +11.22% above its 200-day simple moving average

50-day SMA

$130.70
ABT price is currently +1.62% above its 50-day simple moving average

RSI

58.99
ABT 14-day relative strength index is 58.99

Volume

1.27
ABT 30-day relative volume is 1.27

ATR

$3.50
ABT average true range is $3.50

10-day Historical Volatility

14.91%
ABT 10-day historical volatility is 14.91%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.59
ABT last dividend was $0.59 per share, with an ex-dividend date of April 15, 2025

Next Dividend

-
ABT next dividend has not yet been announced

Dividend per share

Dividend per share

$2.20
ABT annual dividend per share is $2.20

Dividend per share Sector Rank

72.73%
ABT annual dividend per share is higher than 72.73% of companies in Healthcare sector

Dividend per share 1-Year Change

+7.84%
ABT annual dividend per share is up +7.84% year-on-year

Dividend per share 3-Year Change

+22.22%
ABT annual dividend per share is up +22.22% over the past 3 years

Dividend yield

Dividend yield

1.66%
ABT annual dividend yield is 1.66%

Dividend yield Sector Rank

42.53%
ABT annual dividend yield is higher than 42.53% of companies in Healthcare sector

Other

Payout ratio

28.62%
ABT annual payout ratio is 28.62%

Dividends paid

$3.84B
ABT annual dividends paid is $3.84 billion

Free cash flow

$6.35B
ABT annual free cash flow is $6.35 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$41.95B
ABT annual revenue is $41.95 billion

Revenue Analysts estimate

$44.58B
ABT annual revenue is currently -5.91% lower than the consensus analysts' forecast

Revenue 1-year change

+4.59%
ABT annual revenue is up +4.59% year-on-year

Revenue Sector rank

97.53%
ABT annual revenue is higher than 97.53% of companies in Healthcare sector

EPS

EPS

$7.64
ABT annual earnings per share is $7.64

EPS Analysts estimate

$5.15
ABT annual earnings per share is currently +48.33% higher than the consensus analysts' forecast

EPS 1-year change

+134.36%
ABT annual earnings per share is up +134.36% year-on-year

EPS Sector rank

97.52%
ABT annual earnings per share is higher than 97.52% of companies in Healthcare sector

Profit

Gross profit

$23.24B
ABT annual gross profit is $23.24 billion

Gross margin

55.41%
ABT annual gross profit margin is 55.41%

Operating profit

$6.83B
ABT annual operating income is $6.83 billion

Operating margin

16.27%
ABT annual operating profit margin is 16.27%

Net income

$13.40B
ABT annual net profit is $13.40 billion

Net margin

31.95%
ABT annual net profit margin is 31.95%

Expenses

Total expenses

$35.13B
ABT annual total expenses is $35.13 billion

Operating expenses

$16.42B
ABT annual total operating expenses is $16.42 billion

Cost of goods sold

$18.71B
ABT annual cost of goods sold is $18.71 billion

Selling, general & administrative expenses

$11.70B
ABT annual SGA is $11.70 billion

Depreciation and amortization

$3.22B
ABT annual depreciation & amortization is $3.22 billion

Interest expense

$559.00M
ABT annual interest expense is $559.00 million

Income tax

-$6.39B
ABT annual income tax is -$6.39 billion

EBIT & EBITDA

EBIT

$7.23B
ABT annual earnings before interest & taxes is $7.23 billion

EBITDA

$9.11B
ABT annual EBITDA is $9.11 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$81.41B
ABT annual total assets is $81.41 billion

Non current assets

$57.76B
ABT annual long term assets is $57.76 billion

Current assets

$23.66B
ABT annual total current assets is $23.66 billion

Cash and cash equivalents

$7.62B
ABT annual cash & cash equivalents is $7.62 billion

Accounts receivable

$6.92B
ABT annual accounts receivable is $6.92 billion

Inventory

$6.19B
ABT annual inventory is $6.19 billion

Liabilities

Total liabilities

$33.51B
ABT annual total liabilities is $33.51 billion

Long term liabilities

$19.36B
ABT annual total long term liabilities is $19.36 billion

Current liabilities

$14.16B
ABT annual total current liabilities is $14.16 billion

Accounts payable

$4.20B
ABT annual accounts payable is $4.20 billion

Debt

Total debt

$15.02B
ABT annual total debt is $15.02 billion

Total debt 1-year change

-3.88%
ABT annual total debt is down -3.88% year-on-year

Long term debt

$13.52B
ABT annual long term debt is $13.52 billion

Short term debt

$1.50B
ABT annual short term debt is $1.50 billion

Equity & Capital

Shareholders equity

$47.66B
ABT annual stockholders equity is $47.66 billion

Book value

$47.66B
ABT annual book value is $47.66 billion

Retained earnings

$47.26B
ABT annual retained earnings is $47.26 billion

Working capital

$9.50B
ABT annual working capital is $9.50 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$8.56B
ABT annual cash flow from operations is $8.56 billion

Cash from operations 1-year change

+17.86%
ABT annual cash flow from operations is up +17.86% year-on-year

Cash from investing

-$2.34B
ABT annual cash flow from investing activities is -$2.34 billion

Cash from investing 1-year change

+25.38%
ABT annual cash flow from investing activities is up +25.38% year-on-year

Cash from financing

-$5.40B
ABT annual cash flow from financing activities is -$5.40 billion

Cash from financing 1-year change

+23.79%
ABT annual cash flow from financing activities is up +23.79% year-on-year

CAPEX

CAPEX

$2.21B
ABT annual capital expenditures is $2.21 billion

CAPEX 1-year change

+0.23%
ABT annual capital expenditures is up +0.23% year-on-year

Free Cash Flow

Free cash flow

$6.35B
ABT annual free cash flow is $6.35 billion

Free cash flow 1-year change

+25.54%
ABT annual free cash flow is up +25.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.41%
ABT annual gross profit margin is 55.41%

Operating margin

16.27%
ABT annual operating profit margin is 16.27%

Net margin

31.95%
ABT annual net profit margin is 31.95%

ROA & ROE

ROA

17.33%
ABT annual return on assets is 17.33%

ROE

30.91%
ABT annual return on equity is 30.91%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ABT price to earnings ratio value is unknown

PE ratio Sector rank

-
ABT price to earnings ratio is unknown

PB Ratio

PB ratio

12.00
ABT price to book ratio is 12.00

PB ratio Sector rank

92.89%
ABT price to book ratio is higher than 92.89% of companies in Healthcare sector

PS Ratio

PS ratio

5.44
ABT price to sales ratio is 5.44

PS ratio Sector rank

65.72%
ABT price to sales ratio is higher than 65.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$237.06B
ABT enterprise value is $237.06 billion

Enterprise value Sector rank

99.59%
ABT enterprise value is higher than 99.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

22.30
ABT EV/EBITDA is 22.30

EV/EBITDA Sector rank

93.03%
ABT EV/EBITDA is higher than 93.03% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.67
ABT annual current ratio is 1.67

Quick ratio

1.23
ABT annual quick ratio is 1.23

Leverage

Debt to equity

0.30
ABT annual debt to equity ratio is 0.30

Interest coverage ratio

12.93
ABT annual interest coverage ratio is 12.93

Risk & Stability

Piotroski F-Score

6
ABT piotroski f-score is 6

Altman Z-Score

5.89
ABT altman z-score is 5.89

Analyst ratings

Recent major analysts updates

Apr 17, 25 Wells Fargo
Overweight
Apr 17, 25 Stifel
Buy
Apr 17, 25 Raymond James
Outperform
Apr 17, 25 RBC Capital
Outperform
Apr 17, 25 Piper Sandler
Overweight
Apr 17, 25 Morgan Stanley
Equal-Weight
Apr 17, 25 Jefferies
Hold
Apr 17, 25 Barclays
Overweight
Mar 10, 25 B of A Securities
Buy
Mar 4, 25 Goldman Sachs
Buy

Institutional Ownership

Similar stocks

NVS logo
Novartis AG (NVS)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ISRG logo
Intuitive Surgical (ISRG)
TMO logo
Thermo Fisher Scientific (TMO)
BSX logo
Boston Scientific (BSX)
NVO logo
Novo Nordisk A/S (NVO)
AMGN logo
Amgen (AMGN)
SYK logo
Stryker (SYK)
  • What is the ticker symbol for Abbott Laboratories?
  • Does Abbott Laboratories pay dividends?
  • What sector is Abbott Laboratories in?
  • What industry is Abbott Laboratories in?
  • What country is Abbott Laboratories based in?
  • When did Abbott Laboratories go public?
  • Is Abbott Laboratories in the S&P 500?
  • Is Abbott Laboratories in the NASDAQ 100?
  • Is Abbott Laboratories in the Dow Jones?
  • When was Abbott Laboratories's last earnings report?
  • When does Abbott Laboratories report earnings?
  • Should I buy Abbott Laboratories stock now?

What is the ticker symbol for Abbott Laboratories?

The ticker symbol for Abbott Laboratories is NYSE:ABT

Does Abbott Laboratories pay dividends?

Yes, Abbott Laboratories pays dividends. The last payment was $0.59, with an ex-dividend date on April 15, 2025

What sector is Abbott Laboratories in?

Abbott Laboratories is in the Healthcare sector

What industry is Abbott Laboratories in?

Abbott Laboratories is in the Medical Devices industry

What country is Abbott Laboratories based in?

Abbott Laboratories is headquartered in United States

When did Abbott Laboratories go public?

Abbott Laboratories's initial public offering (IPO) was on March 17, 1980

Is Abbott Laboratories in the S&P 500?

Yes, Abbott Laboratories is included in the S&P 500 index

Is Abbott Laboratories in the NASDAQ 100?

No, Abbott Laboratories is not included in the NASDAQ 100 index

Is Abbott Laboratories in the Dow Jones?

No, Abbott Laboratories is not included in the Dow Jones index

When was Abbott Laboratories's last earnings report?

Abbott Laboratories's most recent earnings report was on Apr 16, 2025

When does Abbott Laboratories report earnings?

The next expected earnings date for Abbott Laboratories is Jul 18, 2025

Should I buy Abbott Laboratories stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page